Table 2 Efficacy outcomes observed in participants undergoing RLRL therapy compared to conventional myopia treatments.
Study | Arm | Effectiveness | The regression of axial length (AL) |
|---|---|---|---|
Sun 2024 | RLRL OK | AL Increase < 0.3 mm: 85% (12 m), 94% (24 m) 56% (12 m), 75% (24 m) | AL shortening ≥ 0.05 mm: 55% (1 m), 42% (12 m) 3% (1 m), 2% (12 m) |
Xiong 2024 | RLRL + OK OK | AL Increase < 0.10 mm: 86.2% (12 m) 14.3% (12 m) | AL shortening ≥ 0.05 mm: 30.0% (1 m), 42.9% (3 m), 48.3% (6 m), 44.8% (12 m) 12.5% (1 m), 12.5% (3 m), 13.3% (6 m), 7.1% (12 m) |
Chen 2022 | RLRL 0.01% A | AL Increase ≥ 0.36 mm: 9.7% (12 m) 50.0% (12 m) AL Increase < 0.10 mm: 53.2% (12 m) 9.7% (12 m) | AL shortening ≥ 0.05 mm: 42.6%(1 m), 50.0% (3 m), 31.7% (6 m), 20.6% (12 m) 7.4% (1 m), 10.0% (3 m), 5.2% (6 m), 3.6% (12 m) |
Yu 2024 | RLRL + OK OK | - - | AL shortening ≥ 0.05 mm: 63.6% (12 m); AL shortening ≥ 0.10 mm:45.4% (12 m); AL shortening ≥ 0.20 mm:20% (12 m); AL shortening ≥ 0.30 mm:10.9% (12 m); AL shortening ≥ 0.40 mm:5.4% (12 m) - |
Fu 2024 | RLRL 0.01% A | - | AL shortening ≥ 0.05 mm: 62.22% (6 m) 9.52% (6 m) |
Xiong 2021 | LILT OK | - | - |
Li 2023 | RLRL OK | AL Increase < 0.10 mm: 90.0% (3 m) 93.3% (3 m) | AL shortening: 56.7% (3 m) 23.3% (3 m) |
